drugdevelopment.kableintelligence.com Review:

Drug Development Technology - Drug Development Technology is a procurement and reference site providing a one-stop-shop for professionals and decision makers within the global Drugdevelopment industry

  • https://drugdevelopment.kableintelligence.com/projects/exondys-51-eteplirsen-for-the-treatment-of-duchenne-muscular-dystrophy-dmd Exondys 51 (eteplirsen) for the Treatment of Duchenne Muscular Dystrophy (DMD) - Drug Development Technology - Exondys 51 (eteplirsen) is an injectable solution developed by Sarepta Therapeutics.It is indicated for the treatment of Duchenne muscular dystrophy (DMD) and the drug is specially indicated to treat patients with dystrophin protein deficiency.A...
  • https://drugdevelopment.kableintelligence.com/projects/carnexiv-carbamazepine-for-the-treatment-of-certain-seizure-types-in-adults Carnexiv (carbamazepine) for the Treatment of Partial, Generalised Tonic-clonic Seizures in Adults - Drug Development Technology - Carnexiv (carbamazepine) is an injectable formulation developed by Lundbeck for partial, generalised tonic-clonic seizures in adult patients who are unable to temporarily take oral medication.The US Food and Drug Administration (FDA) granted...
  • https://drugdevelopment.kableintelligence.com/projects/dupixent-dupilumab-for-the-treatment-of-atopic-dermatitis Dupixent (dupilumab) for the Treatment of Atopic Dermatitis - Drug Development Technology - Dupixent (dupilumab) is an investigational drug being developed by Sanofi and Regeneron as a treatment for moderate to severe atopic dermatitis in adult patients.The US Food and Drug Administration (FDA) granted breakthrough therapy designation to...
  • https://drugdevelopment.kableintelligence.com/projects/ocrevus-ocrelizumab-for-the-treatment-of-multiple-sclerosis Ocrevus (ocrelizumab) for the Treatment of Multiple Sclerosis - Drug Development Technology - Developed by Genentech, Ocrevus (ocrelizumab) is indicated for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis.The US Food and Drug Administration (FDA) granted breakthrough therapy designation for...
  • https://drugdevelopment.kableintelligence.com/news/news.html Industry News - Drug Development Technology - Stay up to date with the latest industry updates from the global Drugdevelopment industry
  • https://drugdevelopment.kableintelligence.com/news/newseurocine-vaccines-begins-phase-iii-study-of-influenza-vaccine-immunose-flu-5646729 Eurocine Vaccines begins Phase I/II study of influenza vaccine Immunose FLU - Drug Development Technology - Eurocine Vaccines has commenced a phase I/II clinical study of the quadrivalent influenza vaccine candidate Immunose FLU, a novel nose drop formulation based on the company's technology Endocine and inactivated split antigens.
  • https://drugdevelopment.kableintelligence.com/news/newsgilead-reports-results-from-phase-3-studies-of-switching-to-descovy-based-regimens-from-truvada-based-regimens-5647339 Gilead reports results from Phase 3 studies of switching to Descovy-based regimens from Truvada-based regimens - Drug Development Technology - Gilead Sciences has reported 96-week data from a Phase 3 study and 48-week data from two Phase 3b studies analysing the safety and efficacy of switching virologically suppressed HIV-1 infected patients from regimens containing Truvada to regimens...
  • https://drugdevelopment.kableintelligence.com/news/newsfaron-starts-enrolling-for-phase-iii-trial-of-traumakine-to-treat-respiratory-disease-in-japan-5646795 Faron begins enrolment for Phase III trial of Traumakine to treat respiratory disease in Japan - Drug Development Technology - Faron Pharmaceuticals has reported that its Japanese licensing partner Maruishi Pharmaceutical has recruited the first patient in the Phase III pivotal clinical trial for the treatment of acute respiratory distress syndrome (ARDS) with FP-1201-lyo...
  • https://drugdevelopment.kableintelligence.com/news/newstwo-studies-confirm-positive-benefit-risk-profile-of-xarelto-in-treating-vte-5645106 Two studies confirm positive benefit-risk profile of XARELTO in treating VTE - Drug Development Technology - Janssen Pharmaceuticals and its development partner Bayer announced results of two new real-world studies, which confirmed the positive benefit-risk profile of XARELTO (rivaroxaban) in treating venous thromboembolism (VTE), or blood clots, and...
  • https://drugdevelopment.kableintelligence.com/news/newsboston-biomedical-begins-phase-iii-canstem303c-study-of-napabucasin-to-treat-colorectal-cancer-5645034 Boston Biomedical begins Phase III CanStem303C study of napabucasin to treat colorectal cancer - Drug Development Technology - Boston Biomedical has dosed the first patient in CanStem303C, a new global Phase III study investigating napabucasin in combination with standard of care (FOLFIRI) in patients with previously treated metastatic colorectal carcinoma (mCRC).
  • https://drugdevelopment.kableintelligence.com/contractors/indexAtoZ.html A to Z List of Drugdevelopment Contractors - Drug Development Technology - Find leading drugdevelopment companies providing equipment, products and services to the drugdevelopment industry
  • https://drugdevelopment.kableintelligence.com/contractors/delivery/malvern-drug-development/ Malvern Instruments - Biopharmaceutical and Drug Development - Drug Development Technology - Malvern offers characterisation tools for molecular analysis and small drug discovery to help accelerate development for the pharmaceutical industry.Systems for critical material attribute informationMalvern has a wide range of experience in small...
  • https://drugdevelopment.kableintelligence.com/contractors/regulatory-affairs/pharmaceutical-developmentgroup/ Pharmaceutical Development Group - Pharmaceutical Consultant and FDA Regulatory Strategist - Drug Development Technology - PDG provides pharmaceutical consulting as a regulatory strategist to firms located around the world, and has since 1999.We offer one-stop-shopping to include US FDA NDA compilation and submission, design and execution of toxicology and clinical...
  • https://drugdevelopment.kableintelligence.com/contractors/delivery/systag-systems/ SYSTAG Systems Technik - Automation Systems for Small-Molecule Drug and API Development - Drug Development Technology - SYSTAG provides specialist innovative tools for automating chemical synthesis reactions for the pharmaceutical and fine chemicals industry.From laboratory-scale to mini-pilot, SYSTAG's conceptual and automation solutions include controlled...
  • https://drugdevelopment.kableintelligence.com/contractors/organic/pfanstiehl-pharma/ Pfanstiehl - Injectable and HPLE Carbohydrates for Protein Stabilisation and Optimisation - Drug Development Technology - Pfanstiehl is a manufacturer specialising in scale-up development, custom synthesis, and purification of injectable, high-purity low-endotoxin (HPLE) carbohydrates. It also produces highly potent active pharmaceutical ingredients (API), and...
  • https://drugdevelopment.kableintelligence.com/contractors/delivery/softigel-drugdelivery/ Softigel - Contract Development Services and Drug Delivery Systems - Drug Development Technology - Softigel is Procaps' strategic business unit for contract development services. The company supports healthcare and related businesses that develop, manufacture and commercialise pharmaceutical products.Softgel capsules for the drug...
  • https://drugdevelopment.kableintelligence.com/projects/ Drugdevelopment Industry Projects - Drug Development Technology - The latest innovations and future developments in the Drugdevelopment industry from Drug Development Technology, containing in-depth project information and specifications, and project images
  • https://drugdevelopment.kableintelligence.com/projects/ibrance-palbociclib-for-the-treatment-of-metastatic-breast-cancer/ Ibrance (palbociclib) for the Treatment of Metastatic Breast Cancer - Drug Development Technology - Ibrance (palbociclib) is an oral formulation developed by Pfizer for the treatment of metastatic breast cancer in women with disease progression post endocrine therapy.The new drug application (NDA) for Ibrance was submitted to the US Food and...
  • https://drugdevelopment.kableintelligence.com/contractors/ Drugdevelopment Contractors by Category - Drug Development Technology - Find quality drugdevelopment products, suppliers, manufacturers and exporters by category in our B2B marketplace
  • https://drugdevelopment.kableintelligence.com/products/zetasizer-at-dls Zetasizer AT for DLS - Drug Development Technology - The Zetasizer AT combines Malvern's industry leading Dynamic Light Scattering (DLS) technology with two decades of expertise in design and automation of process interfaces for analytical instrumentation.The Zetasizer AT is a fully-automated...

    Country: 217.147.67.97, Europe, GB

    City: -0.1224 , United Kingdom

  • Artistic Soul - Excellent Cleanse

    I can't say that I had a dramatic result of taking this cleanse as others here have experienced; however, as cleanses go (it is not my first cleanse, but it is my first liver cleanse) it is quite excellent. I take pretty good care of my body already. However, I have experienced over the last couple of years some funky skin issues that I have never had before and I was hoping this cleanse would take care of the issue. There has been no difference so far, but I just finished the cleanse a couple of days ago. I will give it time and see what happens. Either way, I think this cleanse is excellent and the price is spot on. I personally get so exhausted with the enormous prices of some so called "health" products. I did have some issues with swallowing the gel capsules at first, but for two weeks I knew I could handle it, so each time I found some way to get them down --- always with a full mouth of liquid and my head tilted back a tiny bit. I will definitely do this cleanse again in about 6 months to a year.

  • Randall Pine - Five Stars

    Great episode, if not the best episode to date. TWD is horror and should make you feel horrible. True to the genre and true to the comics. If you've made it this far in the series you should know that no one is safe. Kirkman set out to take these people(especially Rick) through hell and change them forever. It is what it is and I love it.

  • Ben E - The only *MUST* ACT book

    As a tutor, this book was a tremendous help to both my students and me. It's required reading for all my students, and it would be a terrific resource to anyone who needs to boost their scores. I can't recommend this book highly enough, from the writing to the explanations, they really hit the nail on the head.

  • Jennifer Garton - Unbeatable price for Quality.

    I have bought Dixie paper plates for years locally. As an Amazon Prine Customer I am more regularly looking to Amazon for my household items. I love this produc for its convenience and the price is unbeatable. Thank you. I will only buy my plates from Amazon from here on.

  • THen - Classic Office Humor!

    Dilbert is so funny because it comes so close to the truth! (Sarcasm intended, but only slightly!!!) This is a must read.

  • Eileen - Works really well, but really stinks! Make sure ...

    Works really well, but really stinks! Make sure you have a window open or a fan on. Do NOT stay in the room for very long at one time!